Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO Maintenance in Immune Thrombocytopenia
NCT01805648Phase 3Unknown
- Sponsor
- Peking Union Medical College
- Start
- Feb 2011
- Primary completion
- Aug 2013
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human thrombopoietin in immune thrombocytopenia (ITP), sponsored by Peking Union Medical College. Status: unknown.
02
Drugs
recombinant human thrombopoietin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01805648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01805648.